-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster III

Symposia: Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Shruthi Suryaprakash, MD1, Lei Han, PhD2*, Garret Manquen2*, Varun Katta2*, Damian Krzyzanowski, PhD2*, Jayaram Prasad2*, Nikitha Nimmagada2*, Kalin Mayberry2*, Nana Liu, PhD2*, Yan Ju, PhD3*, Yu Yao, MD2*, Kelsey Ray, MS, MT(ASCP)2*, Marcin Wlodarski, MD, PhD4, Shengdar Q Tsai, PhD2, Jonathan S Yen, PhD2, Mitchell J Weiss, MD, PhD2 and Senthil Velan Bhoopalan, MD, PhD3*

1Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
2Department of Hematology, St. Jude Childrens Research Hospital, Memphis, TN
3Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
4St. Jude Children's Research Hospital, Memphis, TN

Junichiro Kida, MD, PhD1*, Maggie Fricker1*, Emily Stepanchick2* and Timothy Chlon, PhD3

1Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, CINCINNATI, OH
2Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
3Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Usua Oyarbide, PhD1, Valentino Bezzerri, PhD2, Morgan Staton3*, Christian Boni, PhD4*, Arish Shah5*, Marco Cipolli, MD2*, Eliezer Calo5* and Seth J Corey, MD6

1Cleveland Clinic, Cleveland, OH
2Cystic Fibrosis Center, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
3Cleveland Clinic, Cleveland
4Azienda Ospedaliera Universitaria Integrata, Verona, Italy
5MIT, Cambridge, MA
6Departments of Pediatrics and Cancer Biology, Cleveland Clinic, Cleveland, OH

Koichi R. Katsumura1,2, Peng Liu3*, Jeong-Ah Kim, PhD1,2*, Charu Mehta, PhD1,2*, Vu L. Tran1,2, Mabel M. Jung1,2, Kirby D. Johnson1,2* and Emery H. Bresnick1,2

1Wisconsin Blood Cancer Research Institute, Department of Cell and Regenerative Biology, University of Wisconsin School of Medicine and Public Health, Madison, WI
2UW Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI
3UW Carbone Cancer Center, Department of Biostatistics and Biomedical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, WI

Lauren Harmon, PhD1, Zachary S Hattig, MS2*, Yizhou Peter Huang, BS3,4, Caliese Beckford4*, Xiaotu Ma, PhD5, Rhonda E. Ries, MA6*, Soheil Meshinchi, MD, PhD6, Lucy A. Godley, MD, PhD2 and Timothy J Triche Jr., PhD3,4,7

1Van Andel Institute, GRAND RAPIDS, MI
2Northwestern University, Chicago, IL
3Michigan State University, East Lansing, MI
4Van Andel Institute, Grand Rapids, MI
5St. Jude Children's Research Hospital, Memphis, TN
6Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
7University of Southern California, Los Angeles, CA

Inci Aydemir, MD1*, Xu Han, PhD1*, Honghao Bi, PhD2, Ermin Li, Ph.D.1*, Kehan Ren, PhD1, Pan Wang, Ph.D.1*, Madina Sukhanova3*, Lucy A. Godley, MD, PhD3 and Peng Ji, MD, PhD1

1Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL
2Northwestern University, Wilmette, IL
3Northwestern University, Chicago, IL

Luiz Fernando Bazzo Catto, MD1,2, Nidhi Aggarwal, BS3*, Ruba Shalhoub4*, Natthakan Thongon, PhD5, Tania Rene Machado, RN, BSN6*, Ivana Darden, RN7*, Jennifer Lotter, ms7, Bhavisha A. Patel, MD7, Geraldine Aubert, PhD8*, Colin O. Wu, PhD4*, Simona Colla, PhD9, Cynthia E. Dunbar, MD10, Fernanda Rodrigues, PhD11* and Emma M. Groarke, MD7

1Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute, Bethesda, MD
2Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute, Ribeirão Preto, Brazil
3Hematology Branch, National Heart, Lung and Blood Institute, Bethesda
4Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
6Office of Research Nurses, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
7Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
8British Columbia Cancer Agency, Vancouver, BC, CAN
9Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
10Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NHLBI/NIH, Bethesda, MD
11Hematology Branch, National Heart Lung and Blood Institutes, National Institutes of Health, Bethesda

Leah Swartzrock1,2,3*, Wenjing Pan4*, Mark R. Krampf1,2,3*, Hana Hoang, MS1,2,3*, Morgane Denis1,2,3*, Taylor Cool, PhD1,2,3*, Katie Ho1,2,3*, Miranda Steele4*, Brittany Brown4*, Jian Han, MD, PhD4*, Tippi C. MacKenzie, MD5,6* and Agnieszka D. Czechowicz, MD, PhD1,2,3

1Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
2Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
3Center for Definitive and Curative Medicine, Stanford University School of Medicine, Stanford, CA
4iRepertoire Inc., Huntsville, AL
5Department of Surgery, University of California, San Francisco, San Francisco, CA
6Eli & Edythe Broad Center for Regeneration Medicine, University of California, San Francisco, San Francisco, CA

Valeria Visconte, PhD1, Carlos Bravo-Perez, MD2*, Arda Durmaz, PhD2*, Zachary Brady2*, Luca Guarnera, MD2,3*, Matteo D'Addona2,4*, Carmelo Gurnari, MD, PhD2,3, Chao-Yie Yang, PhD5 and Jaroslaw Maciejewski2

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
2Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
3Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
4Hematology and Transplant Center, University Hospital “San Giovanni di Dio e Ruggi d’Aragona”, Ercolano, Italy
5University of Tennessee Health Science Center, Department of Pharmaceutical Sciences, Memphis, TN

*signifies non-member of ASH